Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2

INTRODUCTION: Accurate and sensitive measurement of antibodies is critical to assess the prevalence of infection, especially asymptomatic infection, and to analyze the immune response to vaccination during outbreaks and pandemics. A broad variety of commercial and in-house serological assays are ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Auerswald, Heidi, Eng, Chanreaksmey, Lay, Sokchea, In, Saraden, Eng, Sokchea, Vo, Hoa Thi My, Sith, Charya, Cheng, Sokleaph, Delvallez, Gauthier, Mich, Vann, Meng, Ngy, Sovann, Ly, Sidonn, Kraing, Vanhomwegen, Jessica, Cantaert, Tineke, Dussart, Philippe, Duong, Veasna, Karlsson, Erik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121123/
https://www.ncbi.nlm.nih.gov/pubmed/35602487
http://dx.doi.org/10.3389/fmed.2022.864972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121123/
https://www.ncbi.nlm.nih.gov/pubmed/35602487
http://dx.doi.org/10.3389/fmed.2022.864972

Ejemplares similares